ISSN 1612-3352

Editors in Chief

Prof. Dr. Claus F. Claussen, Neurootological Research Institute of the Research Society for Smell, Taste, Hearing and Equilibrium Disorders at Bad Kissingen (4-G-F). Bad Kissingen, Germany.
Dr. med. Julia M. Bergmann,
Dr. med. Guillermo O. Bertora,
Otoneuroophthalmological Neurophysiology,
Buenos Aires, Argentina.

Production Managers

Dr. med. Julia M. Bergmann,
Dr. med. Guillermo O. Bertora,
Otoneuroophthalmological Neurophysiology,
Buenos Aires, Argentina.


Associated Editors


The editors welcome authors to submit articles for publications in the ASN.

Read the Information for Authors.


Kurhausstraße 12
D-97688 Bad Kissingen
Germany
Telefon +49-971-6 4832
Fax +49- 971- 6 8637
Email asn@neurootology.org

 

Archived under the topic

Neurootologic therapy

Treatment of severe meniere´s disease using gentamycine and betamethazone labyrinth perfusion

For Meniere`s Disease (M.D.) patients, we are using Betahistin as standard therapy & additionally Urea or Acetazolamide for the attack periods, with good results. But in severe cases of invalidating M.D. causing extensive vertigo, we are using since 6 years labyrinth perfusion by a solution of Gentamycine and Betamethazon. Methods: After insertion of a large […]


A choice of disease for studying vestibular compensation in man : the betahistine example

The author proposes, as disease for the study of drugs activity on vestibular compensation mechanisms in man, a peripheral labyrinthine disease without spontaneous nystagmus of type II or III. He evaluates the state of compensation by the evolution of static posturography parameters and by the score of Norre’s VHT (vestibular habituation training) during an observation […]


Intratympanic dexamethasone treatment for control of subjective idiopathic tinnitus: our clinical experience

In this report, we summarize our clinical experience with intratympanic dexamethasone treatment (IDT) for control of tinnitus.


Fixed combination of cinnarizine and dimenhydrinate versus betahistine dimesylate in the treatment of ménière’s disease: a rando

In a randomized, double-blind clinical study, we evaluated the efficacy and tolerability of the fixed combination of cinnarizine, 20 mg, and dimenhydrinate, 40 mg (Arlevert [ARL]) in comparison to betahistine dimesylate (12 mg) in 82 patients suffering from Ménière’s disease for at least 3 months and showing the characteristic triad of symptoms (paroxysmal vertigo attacks, […]


About balance on platform: mathematical modeling for clinical evaluation

This paper describes, from a technologic and mathematical point of view, a systematic method for daily patient’s equilibrium evaluation during the clinical work.


Cognitive disorders: diagnosis and treatment

During the last half century, medical developments have expedited an increase of expectation of life, all over the world. This extension of life has made that some pathologies that in former years were considered of low prevalence, nowadays they have become top priority for public health.


Response of human skull to bone-conducted sound in the audiometric-ultrasonic range

Some new therapies for tinnitus employ bone-conducted sound in the high audio and ultrasonic frequencies, but there has been little previous research on sound transmission through the head at these frequencies.


Una nuova proposta riabilitativa per i disordini dell’equilibrio di origine cervicale:tecnica e.s.a.c.

L’autore espone una nuova tecnica riabilitativa elaborata e proposta per i disordini dell’equilibrio. Tale tecnica denominata E.S.A,C (.elasticizzazione,scollamento,allenamento,calore), si basa sul ripristino dell’ elasticità dei tessuti molli del distretto cervico_brachiale e torace ,attraverso il movimento attivo ripetuto, lo scollamento, e l’uso di calore esogeno. In questo lavoro vengono presentati i risultati ottenuti nel corso degli […]


The early kinetics of gentamicin uptake into the inner ear

Transtympanic gentamicin administration has become a popular modality in the treatment of Ménière’s disease. This modality and other inner-ear medical therapy are gaining increased clinical and scientific attention.


Gaba – benzodiazepine – chloride receptor – targeted therapy for tinnitus control: preliminary report

Our goal was to attempt to establish neuropharmacological tinnitus control (i.e., relief) with medication directed to restoration of a deficiency in the g-aminobutyric acid – benzodiazepine – chloride receptor in tinnitus patients with a diagnosis of a predominantly central type tinnitus.


Login

Registration

If you are not already registered, please register here for free.

If you are registered but have forgotten your password (or you never had one), click here to recover your password.

Proceedings of

Authors

Archives

2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |

(bi)gital»